Reader Comments

Post a new comment on this article

Response to Aasa Reidak

Posted by plosmedicine on 30 Mar 2009 at 23:56 GMT

Author: Julio Licinio
Position: Professor and Chairman of Psychiatry
Institution: University of Miami
E-mail: licinio@miami.edu
Submitted Date: June 20, 2006
Published Date: June 21, 2006
This comment was originally posted as a “Reader Response” on the publication date indicated above. All Reader Responses are now available as comments.

In response to the query regarding Eli Lilly, I must say that I completely disclose all my activities, and that is why Aasa Reidak was able to write her note. I had published before on this topic in Nature Reviews Drug Discovery and had data (which were widely known to all in the field, including Eli Lilly) that since fluoxetine was introduced, prescriptions had gone up and suicide rates had gone down. There is nothing really conceptually new there. That what was presented at one of Eli Lilly's regular, weekly, invited scientific sessions, which exist at most research institutions, including Lilly Research Laboratories. The paper published here is on the modelling of suicide rates using pre-1988 data to estimate what suicide rates would be now and therefore to predict a potential putative effect of fluoxetine/SSRI's. That mathematical modelling data are new to this paper, and that entire analysis and manuscript content took place without knowledge, support, or input by Eli Lilly.

No competing interests declared.